Usefulness of Statin Pretreatment to Prevent Contrast-Induced Nephropathy and to Improve Long-Term Outcome in Patients Undergoing Percutaneous Coronary Intervention

A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention

Roxana Mehran, Eve Aymong, Eugenia Nikolsky et al. · Journal of the American College of Cardiology · 2004 · 2K citations

Medicine, Cardiology, Radiology +16

Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention

Charanjit S. Rihal, Stephen C. Textor, Diane E. Grill et al. · Circulation · 2002 · 1.7K citations

Medicine, Cardiology, Internal Medicine +15

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.

Octavio Hernández‐Perera, Dolores Pérez‐Sala, R. Sánchez-Pascuala et al. · Journal of Clinical Investigation · 1998 · 764 citations · Full text

Medicine, Pharmacology, Biochemical Pharmacology +12

The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency

Luis Gruberg, Gary S. Mintz, Roxana Mehran et al. · Journal of the American College of Cardiology · 2000 · 748 citations

Medicine, Cardiology, Nephrology +17

Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery

Giuseppe Patti, Massimo Chello, Dario Candura et al. · Circulation · 2006 · 622 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +12